O. Bezençon

发表

Design and optimization of new piperidines as renin inhibitors.

L. Prade, A. Treiber, D. Bur, 2010, Bioorganic & medicinal chemistry letters.

Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors.

L. Prade, A. Treiber, S. Delahaye, 2009, Journal of medicinal chemistry.

New classes of potent and bioavailable human renin inhibitors.

L. Prade, A. Treiber, S. Delahaye, 2009, Bioorganic & medicinal chemistry letters.

Human renin in complex with remikiren

L. Prade, D. Bur, W. Fischli, 2008 .

Design and optimization of a substituted amino propanamide series of renin inhibitors for the treatment of hypertension.

C. Bayly, S. Gagné, S. Soisson, 2010, Bioorganic & medicinal chemistry letters.

Piperidine-based renin inhibitors: upper chain optimization.

L. Prade, A. Treiber, D. Bur, 2010, Bioorganic & medicinal chemistry letters.

Alkylations of Chiral Imidazolidinones Derived from Di‐ and Triglycine and Attempts at Cyclisations to Give Cycloisodityrosines

D. Seebach, O. Bezençon, 2006 .

Discovery of a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate for the Treatment of Generalized Epilepsies.

R. de Kanter, Simon Stamm, E. A. Ertel, 2017, Journal of medicinal chemistry.

Further C‐Alkylations of Cyclotetrapeptides via Lithium and Phosphazenium (P4) Enolates: Discovery of a New Conformation

B. Jaun, D. Seebach, W. Schweizer, 1996 .

Preparation, Antiepileptic Activity, and Cardiovascular Safety of Dihydropyrazoles as Brain-Penetrant T-Type Calcium Channel Blockers.

J. Mosbacher, E. A. Ertel, O. Bezençon, 2016, Journal of medicinal chemistry.

Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers.

R. de Kanter, Olivier Corminboeuf, O. Bezençon, 2016, Journal of Medicinal Chemistry.

Discovery and evaluation of Cav3.2-selective T-type calcium channel blockers.

E. A. Ertel, O. Bezençon, L. Remeň, 2017, Bioorganic & medicinal chemistry letters.

Discovery and evaluation of Cav3.1-selective T-type calcium channel blockers.

E. A. Ertel, O. Bezençon, L. Remeň, 2017, Bioorganic & medicinal chemistry letters.